Skip to main content

Research News

  • Scientists Discover How Lung Cancer Cells Change Identity to Escape Treatment

    Researchers at University of Southampton have uncovered a key mechanism that allows lung cancer cells to become more aggressive and resistant to treatment by switching back to an earlier developmental state.
  • Scientists Discover New Way to Make Immunotherapy More Effective in Breast Cancer
    Researchers from Medical University of Vienna have identified a major mechanism that allows breast cancer tumours to escape the body’s immune system, opening the door for more effective immunotherapy treatments in the future.
  • NTU Singapore Develops Seed-Sized “5-in-1” Surgical Robot for Future Medical Procedures

    Scientists at Nanyang Technological University, Singapore have developed an ultra-small surgical robot capable of performing five different medical functions wirelessly inside the body, marking a major step toward more precise and minimally invasive treatments.

  • Senolytic Drug Combination Delays Early Intervertebral Disc Degeneration in Mice
    Intervertebral disc degeneration is a major cause of chronic back and neck pain, yet current treatments largely focus on symptom relief rather than preventing disease progression. A growing body of evidence suggests that cellular senescence, where cells lose proliferative capacity and secrete inflammatory factors, plays a central role in accelerating disc tissue breakdown.
  • AI-Driven Antibody Engineering Produces More Powerful Broad-Spectrum Ebola Treatment Candidates
    Researchers in China have developed a new computational pipeline that could accelerate the creation of stronger, broader Ebola virus antibodies capable of targeting multiple deadly Ebola species at once. The study demonstrates how artificial intelligence-guided antibody engineering may help scientists stay ahead of rapidly evolving viral threats.
  • Eli Lilly’s Retatrutide Helps Patients Lose Up to 28.3% Body Weight

    Eli Lilly has announced encouraging results from its late-stage Phase 3 clinical trial of retatrutide, an investigational next-generation obesity treatment that delivered dramatic weight reduction in adults living with obesity or overweight conditions.

  • Targeted Therapy Helps Children With Rare Bone Disease Regain Mobility

    A promising targeted therapy may offer new hope to children and adults living with fibrous dysplasia, a rare bone disorder that weakens bones and severely affects mobility. Researchers have reported that the drug burosumab significantly improved phosphate balance and physical function in patients suffering from the debilitating condition.

  • Pluvicto cuts PSA progression risk by 58% in metastatic hormone-sensitive prostate cancer data

    Novartis announced new data from PSMAddition demonstrating improved prostate-specific antigen (PSA) responses with Pluvicto® (lutetium (177Lu) vipivotide tetraxetan) combined with standard of care (SoC) in PSMA-positive metastatic hormone sensitive prostate cancer (mHSPC). Data were presented as a rapid oral presentation at the American Urological Association Annual Meeting 2026.

  • Alzheimer’s Memory Loss Linked to Dopamine Deficiency, Scientists Discover

    Researchers have uncovered a surprising new mechanism behind memory loss in Alzheimer’s disease, identifying dopamine deficiency as a major contributor to cognitive decline. The discovery could open the door to new treatment approaches aimed at restoring memory in patients suffering from the disease.

    The study was led by scientists at Tohoku University in collaboration with researchers from the University of California, Irvine. Their findings were published in the journal Nature Neuroscience on April 23, 2026.

  • Scientists Develop Protective Gel That May Eliminate Need for Daily Insulin Injections

    A major breakthrough in diabetes research could one day free patients with type 1 diabetes from lifelong insulin injections. Researchers from Université de Genève and Geneva University Hospitals have developed an innovative protective hydrogel capable of supporting insulin-producing cells after transplantation, successfully restoring blood sugar control in diabetic mice.

Subscribe to Research News